Assessment of improvement was carried out according to the following parameters: subjective (all patients showed improvement in well-being) and objective (increase in exercise tolerance, correction of lipid metabolism disorders, decrease in the level of MMP-9/TIMP-1 complex, increase in the level of nitric oxide metabolites, improvement of the immune status, correction of endothelial dysfunction). The gene discussed is MMP9; the disease is endothelial dysfunction.